- Home
- NMAX vs ALVO Comparison
NMAX vs ALVO Comparison
Compare NMAX & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMAX
- ALVO
- Stock Information
- Founded
- NMAX 1998
- ALVO 2013
- Country
- NMAX United States
- ALVO Luxembourg
- Employees
- NMAX N/A
- ALVO N/A
- Industry
- NMAX
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- NMAX
- ALVO Health Care
- Exchange
- NMAX NYSE
- ALVO Nasdaq
- Market Cap
- NMAX 2.5B
- ALVO 2.5B
- IPO Year
- NMAX 2025
- ALVO N/A
- Fundamental
- Price
- NMAX $13.08
- ALVO $9.26
- Analyst Decision
- NMAX
- ALVO Buy
- Analyst Count
- NMAX 0
- ALVO 1
- Target Price
- NMAX N/A
- ALVO $18.00
- AVG Volume (30 Days)
- NMAX 1.7M
- ALVO 199.0K
- Earning Date
- NMAX 08-15-2025
- ALVO 08-14-2025
- Dividend Yield
- NMAX N/A
- ALVO N/A
- EPS Growth
- NMAX N/A
- ALVO N/A
- EPS
- NMAX N/A
- ALVO 0.34
- Revenue
- NMAX $175,718,517.00
- ALVO $587,890,000.00
- Revenue This Year
- NMAX N/A
- ALVO $35.07
- Revenue Next Year
- NMAX N/A
- ALVO $44.61
- P/E Ratio
- NMAX N/A
- ALVO $26.91
- Revenue Growth
- NMAX 20.18
- ALVO 413.92
- 52 Week Low
- NMAX $11.82
- ALVO $7.35
- 52 Week High
- NMAX $265.00
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- NMAX N/A
- ALVO 44.39
- Support Level
- NMAX N/A
- ALVO $9.06
- Resistance Level
- NMAX N/A
- ALVO $9.42
- Average True Range (ATR)
- NMAX 0.00
- ALVO 0.31
- MACD
- NMAX 0.00
- ALVO -0.13
- Stochastic Oscillator
- NMAX 0.00
- ALVO 33.41
About NMAX NEWSMAX INC
Newsmax Inc is a multi-platform media company. The company provides original news and lifestyle updates from its linear cable television and over-the-top (OTT) news channels, websites, proprietary database, publishing products, and e-commerce products. The Company uses original news and editorial content to draw large numbers of readers to its media outlets to sell advertising, print, and online information products. The Company's business operations are conducted through two operating segments, Broadcasting and Digital. The company generates maximum revenue from the Broadcasting Segment.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.